Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism

To explore disagreements in multiple systematic reviews (SRs) assessing the benefit-to-harm ratio of thrombolytic therapy in patients with intermediate-risk pulmonary embolism (PE).

Source: Journal of Clinical Epidemiology - November 21, 2017 Category: Epidemiology Authors: Nicoletta Riva, Livia Puljak, Lorenzo Moja, Walter Ageno, Holger Sch ünemann, Nicola Magrini, Alessandro Squizzato Tags: Original Article Source Type: research